Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 11/2015

01-11-2015 | Original Contributions

Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source

Authors: Michel Bouchoucha, Marinos Fysekidis, Chantal Julia, Gheorghe Airinei, Jean-Marc Catheline, Gérard Reach, Robert Benamouzig

Published in: Obesity Surgery | Issue 11/2015

Login to get access

Abstract

Background

Obesity is frequently associated to many functional gastrointestinal disorders. The aim of the present study was to assess the prevalence of functional gastrointestinal disorders in obese patients, according to their body mass index and their recruitment source.

Methods

Five hundred ninety-six obese patients (body mass index (BMI) > 30) filled out a standard questionnaire in order to evaluate the presence of functional gastrointestinal disorders. They were divided into four groups according to the Rome III criteria and their BMI: OF, obese patients from functional gastrointestinal disorder (FGID) enrollment; OO, obese patients from obesity management enrollment; MF, morbid obesity patients from FGID enrollment; and MO, morbid obesity patients from obesity management enrollment. Data analysis was performed using multivariate logistic regression.

Results

Out of the 596 obese patients included in the present study, 183 (33 %) were complaining of FGIDs, while 413 (67 %) were consulting for obesity management. Compared to the OF group, the OO patients had a higher prevalence of females (P = 0.008) and a younger age (P < 0.001). Clinically, they reported a lower incidence of regurgitation (P = 0.044), of chest pain (P = 0.004), of irritable bowel syndrome (IBS; P = 0.035), and of functional diarrhea (P = 0.030). Compared to the MF group, the MO patients had an older age (P = 0.001), a higher BMI (P = 0.013), and clinically by a high frequency of functional dyspepsia (P = 0.006). There were symptoms that had similar prevalence in all groups (OF, OO, MF, MO) such as epigastric pain, postprandial distress, constipation, diarrhea, bloating, abdominal pain soiling, or nonspecific anorectal disorders.

Conclusions

This study has shown that the recruitment source accounted for marked and specific differences in the prevalence of functional gastrointestinal disorders in obesity and morbid obesity. Symptoms with similar prevalence in all groups should be systematically detected in all patients.
Literature
1.
2.
3.
INSERM, editor. ObEpi-Roche 2012: enquête nationale sur l’obésité et le surpoids. 6 ed: INSERM/KANTAR HEALTH/ROCHE; 2013.
4.
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–7.CrossRefPubMed
5.
Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff (Millwood). 2009;28(5):w822–31.CrossRef
6.
Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG, et al. Functional esophageal disorders. Gastroenterology. 2006;130(5):1459–65.CrossRefPubMed
7.
Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466–79.CrossRefPubMed
8.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.CrossRefPubMed
9.
Clouse RE, Mayer EA, Aziz Q, Drossman DA, Dumitrascu DL, Monnikes H, et al. Functional abdominal pain syndrome. Gastroenterology. 2006;130(5):1492–7.CrossRefPubMed
10.
Bharucha AE, Wald A, Enck P, Rao S. Functional anorectal disorders. Gastroenterology. 2006;130(5):1510–8.CrossRefPubMed
11.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377–90.CrossRefPubMed
12.
Talley NJ, Zinsmeister AR, Melton 3rd LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142(1):76–83.PubMed
13.
Clements RH, Gonzalez QH, Foster A, Richards WO, McDowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.CrossRefPubMed
14.
Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004;99(9):1807–14.CrossRefPubMed
15.
Delgado-Aros S, Locke 3rd GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99(9):1801–6.CrossRefPubMed
16.
Mathus-Vliegen EM, Tygat GN. Gastro-oesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol. 2002;37(11):1246–52.CrossRefPubMed
17.
Levy RL, Linde JA, Feld KA, Crowell MD, Jeffery RW. The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol. 2005;3(10):992–6.CrossRefPubMed
18.
Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413–9.CrossRefPubMed
19.
Vakil N. Body mass index and gastroesophageal reflux disease: implications of the obesity epidemic. Dig Dis Sci. 2008;53(9):2291–2.CrossRefPubMed
20.
Fysekidis M, Bouchoucha M, Bihan H, Reach G, Benamouzig R, Catheline JM. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg. 2012;22(3):403–10.CrossRefPubMed
21.
Bouchoucha M, Fysekidis M, Catheline J-M, Airinei G, Reach G, Aparicio T, et al., editors. Modification de la symptomatologie fonctionnelle digestive des patients souffrant d’obésité morbide après chirurgie bariatrique Journées Francophones d’Hépato-gastroentérologie et d’oncologie Digestive; 2014; Paris.
22.
Bouchoucha M, Devroede G, Arsac M. Anismus: a marker of multi-site functional disorders? Int J Colorectal Dis. 2004;19(4):374–9.CrossRefPubMed
23.
Locke 3rd GR, Talley NJ, Fett SL, Zinsmeister AR, Melton 3rd LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106(6):642–9.CrossRefPubMed
24.
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290(1):66–72.CrossRefPubMed
25.
Dutta SK, Arora M, Kireet A, Bashandy H, Gandsas A. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci. 2009;54(6):1243–6.CrossRefPubMed
26.
Andersen LI, Jensen G. Risk factors for benign oesophageal disease in a random population sample. J Intern Med. 1991;230(1):5–10.CrossRefPubMed
27.
Zalar A, Haddouche B, Antonietti M, Alhameedi R, Iwanicki-Caron I, Lecleire S, et al. Lack of correlation between morbid obesity and severe gastroesophageal reflux disease in candidates for bariatric surgery: results of a large prospective study. Obes Surg. 2013;23(11):1939–41.CrossRefPubMed
28.
Swartz DE, Mobley E, Felix EL. Bile reflux after Roux-en-Y gastric bypass: an unrecognized cause of postoperative pain. Surg Obes Relat Dis. 2009;5(1):27–30.CrossRefPubMed
29.
Cremonini F, Locke 3rd GR, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006;18(11):987–94.CrossRefPubMed
30.
Lopez-Alvarenga JC, Vargas JA, Lopez LH, Fass R, Sobrino-Cossio S, Higgins P, et al. Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. Arch Med Res. 2009;40(7):576–81.PubMedCentralCrossRefPubMed
31.
Le Pluart D, Sabaté JM, Bouchoucha M, Hercberg S, Benamouzig R, Julia C. Functional gastrointestinal disorders in 35,447 adults and their association with body mass index. Aliment Pharmacol Ther. 2015;In Press.
32.
Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009;33(3):342–53.CrossRef
33.
Santonicola A, Angrisani L, Ciacci C, Iovino P. Prevalence of functional gastrointestinal disorders according to Rome III criteria in Italian morbidly obese patients. ScientificWorldJournal. 2013;2013:532503.PubMedCentralCrossRefPubMed
34.
Aslam M, Slaughter JC, Goutte M, Garrett CG, Hagaman D, Vaezi MF. Nonlinear relationship between body mass index and esophageal acid exposure in the extraesophageal manifestations of reflux. Clin Gastroenterol Hepatol. 2012;10(8):874–8.CrossRefPubMed
35.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.CrossRefPubMed
36.
Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(11):2619–28.CrossRefPubMed
37.
Jacobson BC, Schroy 3rd PC. The skinny on obesity and reflux. Gastroenterology. 2006;130(6):1925–6.CrossRefPubMed
38.
39.
40.
Metadata
Title
Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source
Authors
Michel Bouchoucha
Marinos Fysekidis
Chantal Julia
Gheorghe Airinei
Jean-Marc Catheline
Gérard Reach
Robert Benamouzig
Publication date
01-11-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 11/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1679-6

Other articles of this Issue 11/2015

Obesity Surgery 11/2015 Go to the issue

How I Do It

Comparison of Reinforcement Techniques Using Suture on Staple-Line in Sleeve Gastrectomy

Letter to the Editor

Outcome Measures in Bariatric Surgery

Original Contributions

Three-Dimensional (3D) Versus Two-Dimensional (2D) Laparoscopic Bariatric Surgery: a Single-Surgeon Prospective Randomized Comparative Study

Original Contributions

Contraceptive Use Before and After Gastric Bypass: a Questionnaire Study

Original Contributions

Internal Hernia After Laparoscopic Antecolic Roux-en-Y Gastric Bypass

Letter to Editor\/LED Reply

Reply to Letter to the Editor: Bariatric Surgery Worldwide 2013 Reveals a Rise in Mini-Gastric Bypass